| Mar'18 | Mar'17 | Mar'16 | Mar'15 | Mar'14 | Mar'13 | Mar'12 |
|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||
Net income | ||||||
38,402 | 18,696 | 14,164 | 17,389 | 21,318 | 19,264 | 22,543 |
Gain on disposal of property, plant and equipment | ||||||
132 | 32 | 13 | -4 | 5 | -172 | 18 |
Depreciation of property, plant and equipment | ||||||
7,329 | 6,662 | 7,062 | 7,419 | 5,219 | 5,032 | 3,928 |
Amortization of intangible assets | ||||||
737 | 672 | 717 | 745 | 743 | 744 | 734 |
Deferred income taxes | ||||||
-1,584 | -3,071 | -164 | -147 | 1,351 | -31 | -758 |
Provision for doubtful accounts | ||||||
5,056 | 4,297 | 3,141 | 4,040 | 2,891 | 1,202 | 1,999 |
Interest on convertible notes | ||||||
163 | 8,648 | 7,754 | 7,003 | 2,226 | - | - |
Cumulative interests on convertible notes | ||||||
- | - | - | - | - | -4,314 | - |
Amortization of debt issuance costs | ||||||
110 | 573 | 576 | 582 | 581 | 493 | - |
Share-based compensation | ||||||
13,434 | 9,042 | 9,101 | 2,667 | - | - | - |
(Gain)/loss on trading securities | ||||||
- | - | -80 | 32 | - | - | - |
Impairment loss on available-for-sale equity securities | ||||||
- | 368 | 1,297 | - | - | - | - |
Loss on disposal of available-for-sale equity securities | ||||||
-27 | - | - | - | - | - | - |
Trading securities | ||||||
- | - | -1,155 | 1,215 | - | -57 | - |
Accounts receivable | ||||||
-1,010 | -1,802 | -790 | 3,109 | 2,621 | -537 | 4,364 |
Non-current prepayments | ||||||
- | - | - | - | - | -244 | -541 |
Inventories | ||||||
-46 | 1,034 | 1,647 | 332 | 4,822 | 1,398 | 474 |
Prepaid expenses and other receivables | ||||||
688 | -1,020 | 743 | -2,809 | 4,093 | 559 | 266 |
Non-current deposits | ||||||
-1 | -2 | -2 | -2 | -43 | - | - |
Accounts payable | ||||||
50 | -144 | 89 | 363 | 86 | 571 | 206 |
Accrued expenses and other payables | ||||||
1,311 | -369 | -4,477 | 45 | 1,775 | 6,775 | 1,499 |
Deferred revenue | ||||||
55,338 | 45,667 | 40,228 | 48,263 | 51,118 | 46,684 | 26,623 |
Amounts due to related parties | ||||||
-746 | -7,246 | 4,944 | -88 | 1,676 | 1,752 | - |
Income tax payable | ||||||
960 | 415 | -241 | 1,211 | -388 | -155 | -828 |
Other non-current liabilities | ||||||
9,704 | 6,668 | 6,290 | 8,342 | 9,128 | 7,468 | 4,825 |
Net cash provided by operating activities | ||||||
130,528 | 92,636 | 90,105 | 95,961 | 86,226 | 93,166 | 56,190 |
Cash flows from investing activities: | ||||||
Purchase of property, plant and equipment | ||||||
10,692 | 3,587 | 2,579 | 6,097 | 24,145 | 36,427 | 6,846 |
Purchase of intangible assets | ||||||
- | - | - | - | - | 0 | 12,734 |
Deposit for acquisition of property, plant and equipment | ||||||
- | - | - | - | - | 0 | - |
Investment deposit | ||||||
- | - | - | - | - | 34,321 | - |
Proceeds from disposal of property, plant and equipment | ||||||
59 | 40 | 23 | 2 | 34 | 72 | 57 |
Acquisition of available-for-sale equity securities | ||||||
- | 9,611 | - | 750 | - | - | - |
Proceeds from disposal of available-for-sale equity securities | ||||||
35 | - | - | - | - | - | - |
Acquisition of other investment | ||||||
- | - | - | - | - | 8,818 | - |
Investment in available-for-sale equity securities | ||||||
- | - | - | - | - | 0 | - |
Net cash used in investing activities | ||||||
-10,598 | -13,158 | -2,556 | -6,845 | -24,111 | -79,494 | -19,523 |
Cash flows from financing activities: | ||||||
Repayment of bank loan | ||||||
- | 8,717 | 9,305 | 9,679 | 8,043 | 7,245 | 7,146 |
Proceeds from bank loan | ||||||
- | - | 9,305 | 9,679 | 9,652 | 8,050 | 7,146 |
Proceeds from issuance of shares upon public offering | ||||||
- | - | - | - | - | 0 | - |
Proceeds from issuance of shares upon exercise of warrants | ||||||
- | - | - | - | - | 0 | - |
Payment of offering and reverse recapitalization costs | ||||||
- | - | - | - | - | 0 | - |
Payment for repurchase of shares | ||||||
- | - | - | - | 711 | 20,419 | 7,092 |
Net proceeds from sale of treasury stock and acquisition of non-controlling interests | ||||||
- | - | - | - | - | 4,077 | - |
Contribution from non-controlling interests | ||||||
- | - | - | - | - | 0 | - |
Proceeds from issuance of convertible notes | ||||||
- | - | - | - | - | 117,617 | - |
Payment for debt issuance costs | ||||||
- | - | - | - | 522 | 2,460 | - |
Payment for dividends to holder of non-controlling interests | ||||||
321 | - | 255 | - | - | - | - |
Net cash used in financing activities | ||||||
-321 | -8,717 | -255 | - | 376 | 99,620 | -7,092 |
Effect of foreign currency exchange rate change on cash and cash equivalents | ||||||
-1,582 | 2,148 | 1,380 | 213 | 54 | -619 | -528 |
Net increase in cash and cash equivalents | ||||||
118,027 | 72,909 | 88,674 | 89,329 | 62,545 | 112,673 | 29,047 |
Payable for property, plant and equipment | ||||||
- | 83 | 36 | - | 6,604 | - | - |
Payable for acquisition of cord blood bank operating right | ||||||
- | - | - | - | - | 0 | - |
Payable for share repurchases | ||||||
- | - | - | - | - | 722 | - |
Payable for debt issuance costs | ||||||
- | - | - | - | - | 522 | - |
Supplemental disclosures of cash flow information: | ||||||
Cash paid for income taxes | ||||||
10,612 | 8,355 | 8,215 | 7,620 | 10,405 | 6,457 | 4,772 |
Cash refund during the year for income taxes | ||||||
- | 232 | 54 | 2,969 | 69 | 66 | 1,657 |
Cash paid for interest | ||||||
245 | 13,665 | 7,688 | 8,048 | 4,520 | 565 | 522 |